tility of Antigen Detecting Tests of Serum and BALF in Diagnosing Respiratory Infectious Diseases
Not Applicable
Recruiting
- Conditions
- Respiratory Infectious Diseases
- Registration Number
- JPRN-UMIN000002727
- Lead Sponsor
- agasaki University Graduate School of Biomedical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 500
Inclusion Criteria
Not provided
Exclusion Criteria
Patients without respiratory diseases
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method corresponding rate of the result of antigen and culture tests
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
How do serum and BALF antigen detection tests compare to PCR for diagnosing RSV and influenza in respiratory infections?
What cytokine biomarkers in BALF correlate with severity of respiratory pathogens detected by antigen tests?
What are the false positive/negative rates of antigen detection in serum versus BALF for atypical respiratory pathogens?
How does antigen detection in BALF improve early diagnosis of Pseudomonas aeruginosa respiratory infections compared to culture methods?
Which molecular targets (e.g., viral nucleocapsid proteins) are most effectively detected by serum antigen tests in respiratory syncytial virus infections?